Bendeka
NDC 63459-348, bendamustine hydrochloride, injection, solution, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 63459-348
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208194
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63459-348 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENDAMUSTINE HYDROCHLORIDE25 mg/mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63459-348-04 | 63459034804 | 1 VIAL, MULTI-DOSE in 1 CARTON (63459-348-04) / 4 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ace9a43b-f9bd-4896-abfe-0ef4fec67ddfMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63459-348
Use it
Look up 63459-348 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63459-348 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63459-348. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.